Literature DB >> 19041830

Serum thyroglobulin determination in thyroid cancer patients.

Zélia Francis1, Martin Schlumberger.   

Abstract

Serum thyroglobulin determination plays a central role, in combination with neck ultrasonography, in the follow-up of thyroid cancer patients. Its specificity is improved by thyroid remnant ablation, and its sensitivity is optimal following prolonged withdrawal or stimulation with recombinant human thyroid-stimulating hormone (TSH). Modern methods with an improved functional sensitivity may facilitate its use during follow-up.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19041830     DOI： 10.1016/j.beem.2008.09.015

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN： 1521-690X            Impact factor:   4.690


  8 in total

1.  Diagnostic value of thyroglobulin measurement in fine-needle aspiration biopsy for detecting metastatic lymph nodes in patients with papillary thyroid carcinoma.

Authors:  Artür Salmaslıoğlu; Yeşim Erbil; Gamze Cıtlak; Feyzullah Ersöz; Serkan Sarı; Aydemir Olmez; Mehtap Tunacı; Dilek Yılmazbayhan; Neşe Colak; Selçuk Ozarmağan
Journal:  Langenbecks Arch Surg       Date:  2010-10-30       Impact factor: 3.445

2.  Current concepts and future directions in differentiated thyroid cancer.

Authors:  Donald S A McLeod
Journal:  Clin Biochem Rev       Date:  2010-02

3.  Clinical utility of an ultrasensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer: can the stimulation test be avoided in patients with an intermediate recurrence risk?

Authors:  A Flores-Rebollar; I Pérez-Díaz; S Lagunas-Bárcenas; B García-Martínez; R Rivera-Moscoso; R Fagundo-Sierra
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-06       Impact factor: 2.124

4.  Factors determining the persistence or recurrence of well-differentiated thyroid cancer treated by thyroidectomy and/or radioiodine in the Boston, Massachusetts area: A retrospective chart review.

Authors:  Angela M Leung; Shalini Dave; Stephanie L Lee; Francis X Campion; Jeffrey R Garber; Elizabeth N Pearce
Journal:  Thyroid Res       Date:  2011-04-15

5.  Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study.

Authors:  Jakob W Kist; Bart de Keizer; Marcel P M Stokkel; Otto S Hoekstra; Wouter V Vogel
Journal:  BMC Cancer       Date:  2014-06-05       Impact factor: 4.430

6.  Diagnostic Performance of 18F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative 131I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb Level.

Authors:  Zhong-Ling Qiu; Wei-Jun Wei; Chen-Tian Shen; Hong-Jun Song; Xin-Yun Zhang; Zhen-Kui Sun; Quan-Yong Luo
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

7.  A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

Authors:  Jorge Alsina; Raul Alsina; Seza Gulec
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-09

8.  Evaluation of Diagnostic Utility of the Immunohistochemical Markers in the Accurate Diagnosis of Thyroid Neoplasms: A Retrospective Study in a Tertiary Care Hospital of Pakistan.

Authors:  Kaleemullah Badini; Saira Fatima; Sajjad Ali Khan; Zafar Suchal; Najmul Islam
Journal:  Cureus       Date:  2022-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.